Company news

Amphastar Pharmaceuticals, Inc. news in 2022

Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference

November 9, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022

November 6, 2022

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022

October 27, 2022

Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference

September 1, 2022

Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Pre-Filled Syringes

August 15, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2022

August 7, 2022

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022

July 31, 2022

Amphastar Receives FDA Approval for Vasopressin

July 18, 2022

Amphastar Receives FDA Approval for Regadenoson

May 23, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022

May 8, 2022

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022

May 1, 2022

Amphastar Receives FDA Approval for Ganirelix Acetate Injection

April 7, 2022

Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

April 5, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021

March 9, 2022

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022

March 2, 2022

Calls in 2022

Decks in 2022